The Claim
In diet-induced obese mice, combination treatment with bimagrumab and semaglutide increases VO2 max by approximately 13% compared to control mice, and this increase is dependent on an increase in lean mass.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In mice made obese by diet, a combination of two drugs called bimagrumab and semaglutide increases their maximum oxygen uptake during exercise by about 13% compared to untreated mice, and this improvement is linked to an increase in muscle mass.
See the scientific wording
In diet-induced obese mice, combination treatment with bimagrumab and semaglutide improves exercise performance (VO2 max) by approximately 13% compared to controls, an effect that is dependent on increased lean mass.
Blocking a specific muscle signal stops muscle breakdown and makes muscles grow bigger, while also helping the body burn fat more efficiently. Bigger muscles require more oxygen to work, so the body gets better at using oxygen during exercise, which lets the animal run longer and harder.
What the research says
1 studyWhen obese mice got both drugs, they kept their muscle and lost more fat, and they could run 13% better — and the scientists say it was because of the extra muscle, not because the drugs directly improved their heart or lungs.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.